Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

about

Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Item

http://www.wikidata.org/entity/Q55340870

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@nl

type

Item

label

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@nl

prefLabel

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Tenelig ...... Randomized Controlled Trials.

@nl

P1476

Efficacy and Safety of Tenelig ...... f Randomized Controlled Trials

@en

P2093

Chongfei Bai

http://www.w3.org/2001/XMLSchema#string

Dalian Qin

http://www.w3.org/2001/XMLSchema#string

Qibing Mei

http://www.w3.org/2001/XMLSchema#string

Shousong Cao

http://www.w3.org/2001/XMLSchema#string

Xiaoxuan Li

http://www.w3.org/2001/XMLSchema#string

Xuefei Huang

http://www.w3.org/2001/XMLSchema#string

Yun Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Teneligliptin in management of type 2 diabetes mellitus

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Use and abuse of HOMA modeling

The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors.

Teneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy.

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus

P304

449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00449

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jianming Wu

P577

2018-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29780322

http://www.w3.org/2001/XMLSchema#string

P932

5946087

http://www.w3.org/2001/XMLSchema#string